87 related articles for article (PubMed ID: 15278000)
1. Bone marrow transplantation in the course of hematological malignancies--follow-up study in blood serum by 31P MRS.
Kuliszkiewicz-Janus M; Baczyński S; Jurczyk A
Med Sci Monit; 2004 Aug; 10(8):CR485-92. PubMed ID: 15278000
[TBL] [Abstract][Full Text] [Related]
2. Application of 31P NMR spectroscopy in clinical analysis of changes of serum phospholipids in leukemia, lymphoma and some other non-haematological cancers.
Kuliszkiewicz-Janus M; Janus W; Baczyński S
Anticancer Res; 1996; 16(3B):1587-94. PubMed ID: 8694531
[TBL] [Abstract][Full Text] [Related]
3. Treatment-induced changes in 31P-MRS (magnetic resonance spectroscopy) spectra of sera from patients with acute leukemia.
Kuliszkiewicz-Janus M; Baczyński S
Biochim Biophys Acta; 1997 Feb; 1360(1):71-83. PubMed ID: 9061042
[TBL] [Abstract][Full Text] [Related]
4. 31P MRS analysis of the phospholipid composition of normal human peripheral blood mononuclear cells (PBMC).
Kuliszkiewicz-Janus M; Tuz MA; Baczyński S; Prajs I; Jaźwiec B
Cell Mol Biol Lett; 2005; 10(3):373-82. PubMed ID: 16217549
[TBL] [Abstract][Full Text] [Related]
5. Application of 31P MRS to the analysis of phospholipid changes in plasma of patients with acute leukemia.
Kuliszkiewicz-Janus M; Tuz MA; Baczyński S
Biochim Biophys Acta; 2005 Oct; 1737(1):11-5. PubMed ID: 16213190
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy-associated changes in 31P MRS spectra of sera from patients with multiple myeloma.
Kuliszkiewicz-Janus M; Baczyński S
NMR Biomed; 1995 May; 8(3):127-32. PubMed ID: 8580000
[TBL] [Abstract][Full Text] [Related]
7. [Significance of dynamic detection of WT1 expression on monitoring minimal residual disease in leukemia patients following allogeneic bone marrow transplantation].
Gu WY; Chen ZX; Hu SY; Zhu J; Wang ZL; Yan F; Wang W; Cen JN; Shen HL; Qian J
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(7):444-7. PubMed ID: 15854547
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of secondary malignancies in adults after allogeneic bone marrow transplantation.
Hasegawa W; Pond GR; Rifkind JT; Messner HA; Lau A; Daly AS; Kiss TL; Kotchetkova N; Galal A; Lipton JH
Bone Marrow Transplant; 2005 Jan; 35(1):51-5. PubMed ID: 15516939
[TBL] [Abstract][Full Text] [Related]
9. Lung function, pulmonary complications, and mortality after allogeneic blood and marrow transplantation in children.
Kaya Z; Weiner DJ; Yilmaz D; Rowan J; Goyal RK
Biol Blood Marrow Transplant; 2009 Jul; 15(7):817-26. PubMed ID: 19539213
[TBL] [Abstract][Full Text] [Related]
10. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience.
Hsieh TJ; Li CW; Chuang HY; Liu GC; Wang CK
J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465
[TBL] [Abstract][Full Text] [Related]
11. Successful renal transplantation following prior bone marrow transplantation in pediatric patients.
Thomas SE; Hutchinson RJ; DebRoy M; Magee JC
Pediatr Transplant; 2004 Oct; 8(5):507-12. PubMed ID: 15367289
[TBL] [Abstract][Full Text] [Related]
12. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX
Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615
[TBL] [Abstract][Full Text] [Related]
13. Unrelated bone marrow transplantation for high-risk anaplastic large cell lymphoma in pediatric patients: a single center case series.
Cesaro S; Pillon M; Visintin G; Putti MC; Gazzola MV; D'Amore E; Scarzello G; Zanesco L; Messina C; Rosolen A
Eur J Haematol; 2005 Jul; 75(1):22-6. PubMed ID: 15946306
[TBL] [Abstract][Full Text] [Related]
14. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
15. Long-term renal function following bone marrow transplantation.
Grönroos MH; Bolme P; Winiarski J; Berg UB
Bone Marrow Transplant; 2007 Jun; 39(11):717-23. PubMed ID: 17401393
[TBL] [Abstract][Full Text] [Related]
16. Normal-looking skin in oncohaematological patients after allogenic bone marrow transplantation is not normal.
Vassallo C; Brazzelli V; Alessandrino PE; Varettoni M; Ardigò M; Lazzarino M; Borroni G
Br J Dermatol; 2004 Sep; 151(3):579-86. PubMed ID: 15377343
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow transplantation in adults with thalassemia: Treatment and long-term follow-up.
Gaziev J; Sodani P; Polchi P; Andreani M; Lucarelli G
Ann N Y Acad Sci; 2005; 1054():196-205. PubMed ID: 16339666
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow-resident memory T cells survive pretransplant chemotherapy and contribute to early immune reconstitution of patients with acute myeloid leukemia given mafosfamide-purged autologous bone marrow transplantation.
Casorati G; Locatelli F; Pagani S; Garavaglia C; Montini E; Lisini D; Turin I; Rossi F; Dellabona P; Maccario R; Montagna D
Exp Hematol; 2005 Feb; 33(2):212-8. PubMed ID: 15676215
[TBL] [Abstract][Full Text] [Related]
19. Magic angle spinning NMR and 1H-31P heteronuclear statistical total correlation spectroscopy of intact human gut biopsies.
Wang Y; Cloarec O; Tang H; Lindon JC; Holmes E; Kochhar S; Nicholson JK
Anal Chem; 2008 Feb; 80(4):1058-66. PubMed ID: 18205334
[TBL] [Abstract][Full Text] [Related]
20. Myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma at the time of second or subsequent remission: long-term follow-up.
Rohatiner AZ; Nadler L; Davies AJ; Apostolidis J; Neuberg D; Matthews J; Gribben JG; Mauch PM; Lister TA; Freedman AS
J Clin Oncol; 2007 Jun; 25(18):2554-9. PubMed ID: 17515573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
